A Roster of HIV/AIDS-Related Resources
Guidelines for Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
Post-exposure Prophylaxis
Healthcare Worker Exposure Guidelineshttp://www.aidsinfo.nih.gov/guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=10&ClassID=3
Non-occupational Exposure Considerationshttp://www.aidsinfo.nih.gov/guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=11&ClassID=3
Management of HIV Complications
Prevention and Treatment of Opportunistic Infectionshttp://www.aidsinfo.nih.gov/guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=211&ClassID=4
Incorporation of HIV Preventionhttp://www.aidsinfo.nih.gov/guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=15&ClassID=4
Testing
Revised Guidelines for Counseling, Testing, and Referralhttp://www.aidsinfo.nih.gov/guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=16&ClassID=5
HIV/AIDS Drugs Data Base
Fact sheets on HIV/AIDS related drugs that describe the drug's use, pharmacology, side effects, and other information.
http://www.aidsinfo.nih.gov/DrugsNew/Default.aspx?MenuItem=Drugs&Search=On
Clinical Trials Search
A ClinicalTrials.gov trial summary.
http://www.aidsinfo.nih.gov/ClinicalTrials/Default.aspx?MenuItem=ClinicalTrials
Vaccines
Information on preventive and therapeutic HIV/AIDS vaccine research.
http://www.aidsinfo.nih.gov/Vaccines/Default.aspx?MenuItem=Vaccines
Can Colonoscopy Interval be Safely Extended from 10 to 15 Years for Individuals at Average CRC Risk?
May 3rd 2024New research suggests the interval "could potentially be extended" without significant harms and could reduce unnecessary invasive procedures. , ie, missed early detection and CRC-specific mortality.